Evidence map›Paper›PMID 21229335›Full record

ArticleClinical reviews in allergy & immunology2012

Geographical differences in autoantibodies and anti-infectious agents antibodies among healthy adults.

Yinon Shapira, Bat-Sheva Poratkatz, Boris Gilburd, Ori Barzilai, Maya Ram, Miri Blank, Staffan Lindeberg, Johan Frostegård, Juan-Manuel Anaya, Nicola Bizzaro and 4 more

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Clinical reviews in allergy & immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Epstein-Barr virus seroprevalence among inflammatory bowel disease patients in Saudi Arabia.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association · 2024
    Article
  5. Frontiers in veterinary science · 2023
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Autoimmunity as the comet tail of COVID-19 pandemic.World journal of clinical cases · 2020
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 7 countries.

Yinon ShapiraThe Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel.
Bat-Sheva Poratkatz
Boris Gilburd
Ori Barzilai
Maya Ram
Miri Blank
Staffan Lindeberg
Johan Frostegård
Juan-Manuel Anaya
Nicola Bizzaro
Luis J Jara
Jan Damoiseaux
Yehuda Shoenfeld
Nancy Agmon Levin
Sheba Medical Center · ILCentro Médico Nacional La Raza · MXHebrew College · USIstituto di Sessuologia Clinica · ITKarolinska University Hospital · SELund University · SEMaastricht University · NLUniversidad del Rosario · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Much is known about the geoepidemiology of defined autoimmune diseases (AD); however, there is currently limited data regarding the prevalence of autoantibodies among healthy populations of different geographical areas. The aim of this study was to evaluate a large profile of autoantibodies in healthy adults from distinct global regions as well as the prevalence of anti-infectious agents antibodies in those regions. Sera samples from 557 healthy donors were obtained at six centers located in different countries (i.e., Italy, Netherlands, Israel, Mexico, Columbia, Papua New Guinea (Kitavans)). Sera were tested for the presence of antinuclear antibodies (ANA) and autoantibodies associated with thrombophilia, vasculitis, and gastrointestinal (GI) disease. Sera samples were also screened for antibodies against infectious agents (i.e., EBV, CMV, HBV, Helicobacter pylori, Treponema pallidum, and Toxoplasma gondii). Tests were performed using the BioPlex 2200 or ELISA kits (Bio-Rad Laboratories, USA). We found a significant gradient of ANA positivity among the groups: 45% of Columbians, 38% of Kitavans, 26% of Mexicans, 12% of Italians, 12% of Dutch, and 11% of Israelis were ANA positive. Geographical differences were also observed regarding the prevalence of specific autoantibodies, namely ANA: anti-dsDNA, chromatin, SmRNP, Ro/SSA, La/SSB, Scl70; GI associated: antigliadin; and thrombophilia-associated: anti-β2GP1 and prothrombin. Additionally, significant differences were observed regarding serological markers of all infectious agents screened. The observed variance between healthy ethno-geographical distinct populations in prevalence of autoantibodies may represent different genetic or environmental (e.g., prior exposure to infection) influences. Thus may illuminate possible causes of geoepidemiological differences in AD.

Indexed as

EthnicityAdultAntibodies, AntinuclearAntibodies, BacterialAntibodies, ViralAutoimmune DiseasesColombiaCross-Sectional StudiesFemaleHumansIsraelItalyMaleMexicoNetherlandsPapua New GuineaAntibodies, AntinuclearAntibodies, BacterialAntibodies, Viral

Identifiers

PMID21229335
OpenAlexW2026692883

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.